|
|||||
|
 | |
| |
| |
| |
| |
| |
|
Gene: CCT6A |
Gene summary for CCT6A |
 Gene summary. |
| Gene information | Species | Human | Gene symbol | CCT6A | Gene ID | 908 |
| Gene name | chaperonin containing TCP1 subunit 6A | |
| Gene Alias | CCT-zeta | |
| Cytomap | 7p11.2 | |
| Gene Type | protein-coding | GO ID | GO:0000723 | UniProtAcc | P40227 |
Top |
Malignant transformation analysis |
| Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
| Malignant transformation involving gene list. |
| Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
| 908 | CCT6A | HTA11_78_2000001011 | Human | Colorectum | AD | 3.85e-04 | 4.43e-01 | -0.1088 |
| 908 | CCT6A | HTA11_347_2000001011 | Human | Colorectum | AD | 2.44e-04 | 3.19e-01 | -0.1954 |
| 908 | CCT6A | HTA11_1391_2000001011 | Human | Colorectum | AD | 4.69e-03 | 4.25e-01 | -0.059 |
| 908 | CCT6A | HTA11_6801_2000001011 | Human | Colorectum | SER | 1.80e-02 | 7.36e-01 | 0.0171 |
| 908 | CCT6A | HTA11_99999970781_79442 | Human | Colorectum | MSS | 4.16e-08 | 5.11e-01 | 0.294 |
| 908 | CCT6A | HTA11_99999965104_69814 | Human | Colorectum | MSS | 2.45e-06 | 7.16e-01 | 0.281 |
| 908 | CCT6A | HTA11_99999971662_82457 | Human | Colorectum | MSS | 7.68e-19 | 7.13e-01 | 0.3859 |
| 908 | CCT6A | HTA11_99999974143_84620 | Human | Colorectum | MSS | 1.95e-03 | 2.84e-01 | 0.3005 |
| 908 | CCT6A | A015-C-203 | Human | Colorectum | FAP | 6.36e-04 | -6.54e-02 | -0.1294 |
| 908 | CCT6A | A001-C-108 | Human | Colorectum | FAP | 2.87e-02 | -7.64e-02 | -0.0272 |
| 908 | CCT6A | A002-C-205 | Human | Colorectum | FAP | 8.09e-04 | -4.90e-02 | -0.1236 |
| 908 | CCT6A | A002-C-114 | Human | Colorectum | FAP | 7.50e-03 | -4.67e-02 | -0.1561 |
| 908 | CCT6A | A015-C-104 | Human | Colorectum | FAP | 3.93e-06 | -8.85e-02 | -0.1899 |
| 908 | CCT6A | A002-C-016 | Human | Colorectum | FAP | 3.78e-02 | -5.99e-02 | 0.0521 |
| 908 | CCT6A | A002-C-116 | Human | Colorectum | FAP | 1.99e-04 | -7.76e-02 | -0.0452 |
| 908 | CCT6A | CRC-3-11773 | Human | Colorectum | CRC | 1.40e-05 | 3.57e-01 | 0.2564 |
| 908 | CCT6A | AEH-subject1 | Human | Endometrium | AEH | 3.73e-08 | -2.48e-01 | -0.3059 |
| 908 | CCT6A | AEH-subject2 | Human | Endometrium | AEH | 1.05e-09 | -2.71e-01 | -0.2525 |
| 908 | CCT6A | AEH-subject3 | Human | Endometrium | AEH | 9.93e-06 | -1.27e-01 | -0.2576 |
| 908 | CCT6A | AEH-subject4 | Human | Endometrium | AEH | 1.77e-02 | -8.85e-02 | -0.2657 |
| Page: 1 2 3 4 5 6 7 8 9 10 |
| Transcriptomic changes along malignancy continuum. |
| Tissue | Expression Dynamics | Abbreviation |
| Colorectum (GSE201348) |  | FAP: Familial adenomatous polyposis |
| CRC: Colorectal cancer | ||
| Colorectum (HTA11) |  | AD: Adenomas |
| SER: Sessile serrated lesions | ||
| MSI-H: Microsatellite-high colorectal cancer | ||
| MSS: Microsatellite stable colorectal cancer | ||
| Endometrium |  | AEH: Atypical endometrial hyperplasia |
| EEC: Endometrioid Cancer | ||
| Esophagus |  | ESCC: Esophageal squamous cell carcinoma |
| HGIN: High-grade intraepithelial neoplasias | ||
| LGIN: Low-grade intraepithelial neoplasias | ||
| Liver |  | HCC: Hepatocellular carcinoma |
| NAFLD: Non-alcoholic fatty liver disease | ||
| Oral Cavity |  | EOLP: Erosive Oral lichen planus |
| LP: leukoplakia | ||
| NEOLP: Non-erosive oral lichen planus | ||
| OSCC: Oral squamous cell carcinoma | ||
| Prostate |  | BPH: Benign Prostatic Hyperplasia |
| Skin |  | AK: Actinic keratosis |
| cSCC: Cutaneous squamous cell carcinoma | ||
| SCCIS:squamous cell carcinoma in situ | ||
| Thyroid |  | ATC: Anaplastic thyroid cancer |
| HT: Hashimoto's thyroiditis | ||
| PTC: Papillary thyroid cancer |
| ∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
| Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
| Figure of enriched GO biological processes. |
| Tissue | Disease Stage | Enriched GO biological Processes |
| Colorectum | AD |  |
| Colorectum | SER |  |
| Colorectum | MSS |  |
| Colorectum | MSI-H |  |
| Colorectum | FAP |  |
| ∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
| Page: 1 2 3 4 5 6 7 8 9 |
| Enriched GO biological processes. |
| GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
| GO:0032204110 | Thyroid | PTC | regulation of telomere maintenance | 52/5968 | 80/18723 | 1.15e-09 | 3.34e-08 | 52 |
| GO:0000723111 | Thyroid | PTC | telomere maintenance | 74/5968 | 131/18723 | 4.85e-09 | 1.26e-07 | 74 |
| GO:005105420 | Thyroid | PTC | positive regulation of DNA metabolic process | 100/5968 | 201/18723 | 9.18e-08 | 1.84e-06 | 100 |
| GO:0007004111 | Thyroid | PTC | telomere maintenance via telomerase | 43/5968 | 69/18723 | 1.88e-07 | 3.48e-06 | 43 |
| GO:2001252111 | Thyroid | PTC | positive regulation of chromosome organization | 48/5968 | 82/18723 | 5.65e-07 | 9.04e-06 | 48 |
| GO:0032206111 | Thyroid | PTC | positive regulation of telomere maintenance | 34/5968 | 52/18723 | 7.04e-07 | 1.10e-05 | 34 |
| GO:190487216 | Thyroid | PTC | regulation of telomerase RNA localization to Cajal body | 16/5968 | 18/18723 | 8.42e-07 | 1.29e-05 | 16 |
| GO:00701989 | Thyroid | PTC | protein localization to chromosome, telomeric region | 22/5968 | 29/18723 | 1.44e-06 | 2.04e-05 | 22 |
| GO:0010833111 | Thyroid | PTC | telomere maintenance via telomere lengthening | 46/5968 | 81/18723 | 3.10e-06 | 4.04e-05 | 46 |
| GO:009067016 | Thyroid | PTC | RNA localization to Cajal body | 16/5968 | 19/18723 | 3.74e-06 | 4.73e-05 | 16 |
| GO:009067116 | Thyroid | PTC | telomerase RNA localization to Cajal body | 16/5968 | 19/18723 | 3.74e-06 | 4.73e-05 | 16 |
| GO:009067216 | Thyroid | PTC | telomerase RNA localization | 16/5968 | 19/18723 | 3.74e-06 | 4.73e-05 | 16 |
| GO:009068516 | Thyroid | PTC | RNA localization to nucleus | 16/5968 | 19/18723 | 3.74e-06 | 4.73e-05 | 16 |
| GO:0006278110 | Thyroid | PTC | RNA-dependent DNA biosynthetic process | 43/5968 | 75/18723 | 4.61e-06 | 5.66e-05 | 43 |
| GO:003221010 | Thyroid | PTC | regulation of telomere maintenance via telomerase | 33/5968 | 53/18723 | 5.10e-06 | 6.20e-05 | 33 |
| GO:190435619 | Thyroid | PTC | regulation of telomere maintenance via telomere lengthening | 36/5968 | 61/18723 | 1.11e-05 | 1.22e-04 | 36 |
| GO:2000278112 | Thyroid | PTC | regulation of DNA biosynthetic process | 55/5968 | 106/18723 | 1.45e-05 | 1.55e-04 | 55 |
| GO:190487416 | Thyroid | PTC | positive regulation of telomerase RNA localization to Cajal body | 13/5968 | 15/18723 | 1.81e-05 | 1.87e-04 | 13 |
| GO:19048169 | Thyroid | PTC | positive regulation of protein localization to chromosome, telomeric region | 11/5968 | 12/18723 | 2.91e-05 | 2.82e-04 | 11 |
| GO:190435823 | Thyroid | PTC | positive regulation of telomere maintenance via telomere lengthening | 24/5968 | 37/18723 | 3.77e-05 | 3.48e-04 | 24 |
| Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 |
| Enriched KEGG pathways. |
| Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
| Page: 1 |
Top |
Cell-cell communication analysis |
| Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
| Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
| Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
| Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
| TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
| ∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
| Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
| Annotation of somatic variants for genes involved in malignant transformation |
| Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
| CCT6A | SNV | Missense_Mutation | rs770231271 | c.1324N>A | p.Asp442Asn | p.D442N | P40227 | protein_coding | tolerated(0.2) | benign(0.012) | TCGA-A8-A094-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
| CCT6A | SNV | Missense_Mutation | c.1115N>C | p.Val372Ala | p.V372A | P40227 | protein_coding | tolerated(0.07) | possibly_damaging(0.588) | TCGA-AN-A0AK-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
| CCT6A | SNV | Missense_Mutation | novel | c.867N>A | p.Phe289Leu | p.F289L | P40227 | protein_coding | deleterious(0.04) | possibly_damaging(0.85) | TCGA-DS-A1OC-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | gemcitabine | SD |
| CCT6A | SNV | Missense_Mutation | novel | c.559N>A | p.Asp187Asn | p.D187N | P40227 | protein_coding | tolerated(0.06) | possibly_damaging(0.558) | TCGA-EA-A3HU-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
| CCT6A | insertion | In_Frame_Ins | novel | c.869_870insCCTAAGATTTAACAG | p.Val290_Val291insLeuArgPheAsnSer | p.V290_V291insLRFNS | P40227 | protein_coding | TCGA-DS-A1OC-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | gemcitabine | SD | ||
| CCT6A | SNV | Missense_Mutation | c.1268N>A | p.Ile423Asn | p.I423N | P40227 | protein_coding | tolerated(0.36) | benign(0.005) | TCGA-A6-6649-01 | Colorectum | colon adenocarcinoma | Male | >=65 | III/IV | Chemotherapy | fluorouracil | SD | |
| CCT6A | SNV | Missense_Mutation | c.464N>A | p.Ser155Tyr | p.S155Y | P40227 | protein_coding | deleterious(0) | probably_damaging(0.98) | TCGA-AA-A010-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Chemotherapy | folinic | CR | |
| CCT6A | SNV | Missense_Mutation | c.650G>A | p.Arg217Gln | p.R217Q | P40227 | protein_coding | deleterious(0.03) | possibly_damaging(0.884) | TCGA-AD-6964-01 | Colorectum | colon adenocarcinoma | Male | <65 | III/IV | Chemotherapy | folfox | PD | |
| CCT6A | SNV | Missense_Mutation | c.1240N>A | p.Val414Met | p.V414M | P40227 | protein_coding | deleterious(0) | possibly_damaging(0.556) | TCGA-AD-A5EJ-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
| CCT6A | SNV | Missense_Mutation | c.1310T>C | p.Val437Ala | p.V437A | P40227 | protein_coding | deleterious(0.03) | benign(0.158) | TCGA-F4-6856-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Ancillary | leucovorin | CR |
| Page: 1 2 3 4 5 6 |
Top |
Related drugs of malignant transformation related genes |
| Identification of chemicals and drugs interact with genes involved in malignant transfromation |
| (DGIdb 4.0) |
| Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
| Page: 1 |
Copyright 2023-Present -The University of Texas Health Science Center at Houston |